Key Proteo, Inc.
PrivateLast Round
Seed
Mar 25, 2026
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Key Proteo, Inc. operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series A round in August 2023.
Key Proteo, Inc. is a biotechnology company that develops proteomics-based diagnostic platforms for the early identification of rare but treatable genetic disorders in newborns.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Key Proteo, Inc. Comparables
Compare Key Proteo, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enfanos, LLC | 78% | |
| Baebies | 76% | |
| LaCAR MDx Technologies | 74% |
For institutional investors. Book with your work email.
Key Proteo, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 25, 2026 | ||||
| Series A | Aug 23, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Key Proteo, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BRV Capital Management | Series A |
| Mint Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
$2.3M raised in Seed round.
- Nov 13, 2024
Monthly visitors grew 116% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Key Proteo, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Key Proteo, Inc.'s valuation, stock price, and market status.
Is Key Proteo, Inc. a public or private company?
Key Proteo, Inc. is a private company.
What is the current stock price of Key Proteo, Inc.?
Key Proteo, Inc. is a private company, so its shares have no public market price. Caplight tracks Key Proteo, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Key Proteo, Inc. worth (valuation)?
Valuation information for Key Proteo, Inc. is not publicly available.
Can I buy Key Proteo, Inc. stock?
Key Proteo, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Key Proteo, Inc.'s last funding round?
Key Proteo, Inc.'s most recent funding round was Seed on March 25, 2026.
Who are the main investors in Key Proteo, Inc.?
Key investors in Key Proteo, Inc. include BRV Capital Management, Mint Venture Partners.
Will Key Proteo, Inc. IPO soon?
No public IPO plans have been announced for Key Proteo, Inc..
How can I track Key Proteo, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Key Proteo, Inc.'s shares on secondary markets.